ResMed stock trades on Nasdaq. Focus stays on sleep apnea demand.

By Julia Smith, Sector & Peers desk. Reviewed on July 7, 2026 at 11:38 a.m. ET.

ResMed Inc. (ISIN US7611521078) trades on Nasdaq, and the company's business still centers on sleep apnea therapy and respiratory care. Investors continue to value the combination of recurring device demand and software-linked patient management.

Business model first

ResMed's core franchise is built around sleep apnea devices, masks and cloud-connected software that support care delivery and adherence monitoring. That mix gives the company a recurring-revenue profile that is different from a pure hardware supplier.

For U.S. investors, the Nasdaq listing matters because it places ResMed alongside other large health care technology and device names with active analyst coverage and deep institutional trading.

What the market watches

The focus for shareholders is usually margin discipline, prescription volume trends and the pace of adoption for connected care tools. Those are the metrics that tend to shape how the market frames the stock over time.

In a sector where durable demand matters, ResMed's installed base remains the key operating advantage. That is the company-specific story that tends to matter most for valuation.

Devices and software

ResMed's product mix spans masks, devices and digital health tools used to support patients with sleep apnea and other respiratory conditions. That product structure is central to the company's revenue base and helps explain why the market follows operating trends so closely.

Stock context

ResMed shares are listed on Nasdaq, and the stock is priced at $0.00 as of July 7, 2026, 11:38 a.m. ET.

This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal.